This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.
Summary:
This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° about how to strategically approach hiring FTEs, insourcing, outsourcing and contracting to be appropriately prepared for the different stages of a biotech companies development from preclinical to early stage to late stage trials to commercialization. Specifically:
- Balancing the mix of hires and outsourcing
- Hiring for skillsets to enable efficiency without overhiring
- Reactive vs proactive hiring
- Building in a stage appropriate way but also hiring in time for later stages
To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
Moderators
Harold Bernstein, MD, PhD
President, R&D and CMO
Maze Therapeutics
Panelists
Matthew Frankel, MD
CMO
Chemomab Therapeutics
Raul P. Lima
EVP, Clinical Operations
inSeption Group
Dan Bloomfield, MD
CMO
Anthos Therapeutics
Jing Marantz, MD, PhD
CMO
Scholar Rock
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.